135 related articles for article (PubMed ID: 17235117)
1. Myopathic (not neuropathic) electrophysiological abnormalities in dynamin 2-related centronuclear myopathy.
Foye PM
Brain; 2007 Feb; 130(Pt 2):e63; author reply e64. PubMed ID: 17235117
[No Abstract] [Full Text] [Related]
2. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
[TBL] [Abstract][Full Text] [Related]
3. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
[TBL] [Abstract][Full Text] [Related]
4. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
5. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
6. A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.
Bitoun M; Bevilacqua JA; Eymard B; Prudhon B; Fardeau M; Guicheney P; Romero NB
Neurology; 2009 Jan; 72(1):93-5. PubMed ID: 19122038
[No Abstract] [Full Text] [Related]
7. Mutations in dynamin 2 cause dominant centronuclear myopathy.
Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
[TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
[TBL] [Abstract][Full Text] [Related]
9. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
10. [Mutations in dynamin 2 cause dominant centronuclear myopathy].
Bitoun M; Romero NB; Guicheney P
Med Sci (Paris); 2006 Feb; 22(2):101-2. PubMed ID: 16457739
[No Abstract] [Full Text] [Related]
11. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
[No Abstract] [Full Text] [Related]
12. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
13. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
15. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial alterations in dynamin 2-related centronuclear myopathy.
Zanoteli E; Vergani N; Campos Y; Vainzof M; Oliveira AS; d'Azzo A
Arq Neuropsiquiatr; 2009 Mar; 67(1):102-4. PubMed ID: 19330221
[No Abstract] [Full Text] [Related]
17. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
18. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
19. Myotonia in DNM2-related centronuclear myopathy.
Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.
Trochet D; Prudhon B; Beuvin M; Peccate C; Lorain S; Julien L; Benkhelifa-Ziyyat S; Rabai A; Mamchaoui K; Ferry A; Laporte J; Guicheney P; Vassilopoulos S; Bitoun M
EMBO Mol Med; 2018 Feb; 10(2):239-253. PubMed ID: 29246969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
